nach oben

Rheumatology International

Erschienen in:

21.03.2022 | Observational Research

Assessment of autonomic dysfunction with the COMPASS-31 and its relationship with disease activity and cardiovascular risks in patients with psoriatic arthritis

verfasst von: Halise Hande Gezer, Didem Erdem Gürsoy, Sevtap Acer Kasman, Mehmet Tuncay Duruöz

Erschienen in: Rheumatology International | Ausgabe 9/2022

Einloggen, um Zugang zu erhalten

Abstract

This study aimed to evaluate the autonomic dysfunction as assessed by the Composite Autonomic Symptom Score-31 (COMPASS-31) as well as its relationship with disease activity and cardiovascular risks in patients with psoriatic arthritis (PsA). This cross-sectional observational study involved 118 PsA patients (85 females, mean age 45.6 years) and 64 healthy subjects. Cardiovascular risks were recorded including body mass index (BMI), hypertension (HT), diabetes mellitus (DM), dyslipidemia, metabolic syndrome (MetS), and 10-year Framingham Risk scores (FRS) were calculated. PsA was assessed with regard to disease activity, quality of life, and function. Autonomic dysfunction was evaluated using the COMPASS-31 consisting of six subdivisions including orthostatic, vasomotor, secretomotor, gastrointestinal, bladder, and pupillomotor functions. The mean disease duration was 63.3 months. The mean total COMPASS-31 score was significantly higher in PsA patients than in controls (24.4 vs 11.1; p < 0.001), as were all sub-domain scores. COMPASS-31 scores were significantly lower in patients with DAPSA-REM and MDA. The COMPASS-31 total score showed significant correlations with scores of pain, global assessment, fatigue, function, quality of life, DAPSA, and BASDAI (p < 0.05).The presence of HT, dyslipidemia, MetS, and abdominal obesity did not significantly affect the total COMPASS-31 and sub-domain scores, except for the secretomotor scores being significantly higher in patients with abdominal obesity and MetS (p < 0.05). COMPASS-31 scores were not significantly different across the FRS risk groups. The symptoms of autonomic dysfunction are prevalent in PsA patients. High disease activity and pain have negative effects on autonomic function, and also functional impairment, fatigue, and poor quality of life are associated with autonomic dysfunction. However, the COMPASS-31 was found to be insufficient to demonstrate a clear relationship between autonomic dysfunction and cardiovascular risk.

Ritchlin CT, Colbert RA, Gladman DD (2017) Psoriatic arthritis. N Engl J Med 376:957–970. https://doi.org/10.1056/nejmra1505557CrossRefPubMed

Fairchild KD, Saucerman JJ, Raynor LL, Sivak JA, Xiao Y, Lake DE, Moorman JR (2009) Endotoxin depresses heart rate variability in mice: cytokine and steroid effects. Am J Physiol Regul Integr Comp Physiol 297:R1019-1027. https://doi.org/10.1152/ajpregu.00132.2009CrossRefPubMedPubMedCentral

Borovikova LV, Ivanova S, Zhang M, Yang H, Botchkina GI, Watkins LR, Wang H, Abumrad N, Eaton JW, Tracey KJ (2000) Vagus nerve stimulation attenuates the systemic inflammatory response to endotoxin. Nature 405:458–462. https://doi.org/10.1038/35013070CrossRefPubMed

Syngle A, Verma I, Garg N, Krishan P (2013) Autonomic dysfunction in psoriatic arthritis. Clin Rheumatol 32:1059–1064. https://doi.org/10.1007/s10067-013-2239-xCrossRefPubMed

Syngle A, Verma I, Krishan P, Garg N, Syngle V (2015) Disease-modifying anti-rheumatic drugs improve autonomic neuropathy in arthritis: DIANA study. Clin Rheumatol 34:1233–1241. https://doi.org/10.1007/s10067-014-2716-xCrossRefPubMed

Moog P, Eren O, Witt M, Rauschel V, Kossegg S, Straube A, Grünke M, Schulze-Koops H (2016) Assessment of autonomic function in a cohort of patients with ANCA-associated vasculitis. Clin Auton Res 26:279–285. https://doi.org/10.1007/s10286-016-0364-8CrossRefPubMed

Ewing DJ, Martyn CN, Young RJ, Clarke BF (1985) The value of cardiovascular autonomic function tests: 10 years experience in diabetes. Diabetes Care 8:491–498. https://doi.org/10.2337/diacare.8.5.491CrossRefPubMed

Singh R, Arbaz M, Rai NK, Joshi R (2019) Diagnostic accuracy of composite autonomic symptom scale 31 (COMPASS-31) in early detection of autonomic dysfunction in type 2 diabetes mellitus. Diabetes Metab Syndr Obes 12:1735–1742. https://doi.org/10.2147/dmso.s214085CrossRefPubMedPubMedCentral

Adler BL, Russell JW, Hummers LK, McMahan ZH (2018) Symptoms of autonomic dysfunction in systemic sclerosis assessed by the COMPASS-31 Questionnaire. J Rheumatol 45:1145–1152. https://doi.org/10.3899/jrheum.170868CrossRefPubMedPubMedCentral

10.

Moog P, Valda K, Eren OE, Rauschel V, Kossegg SJ, Bachmann Q, Schmaderer C, Straube A, Schulze-Koops H, Witt M (2019) A complex pattern of autonomic dysfunction in familial Mediterranean fever. Results from a controlled cross-sectional study. Clin Exp Rheumatol 37(Suppl 121):35–42PubMed

11.

Polachek A, Touma Z, Anderson M, Eder L (2017) Risk of cardiovascular morbidity in patients with psoriatic arthritis: a meta-analysis of observational studies. Arthritis Care Res (Hoboken) 69:67–74. https://doi.org/10.1002/acr.22926CrossRef

12.

Peluso R, Caso F, Tasso M, Ambrosino P, Dario Di Minno MN, Lupoli R, Criscuolo L, Caso P, Ursini F, Puente AD, Scarpa R, Costa On Behalf Of CaRrds Study Group L (2018) Cardiovascular risk markers and major adverse cardiovascular events in psoriatic arthritis patients. Rev Recent Clin Trials 13:199–209. https://doi.org/10.2174/1574887113666180314105511CrossRefPubMedPubMedCentral

13.

Hillebrand S, Gast KB, de Mutsert R, Swenne CA, Jukema JW, Middeldorp S, Rosendaal FR, Dekkers OM (2013) Heart rate variability and first cardiovascular event in populations without known cardiovascular disease: a meta-analysis and dose-response meta-regression. Europace 15:742–749. https://doi.org/10.1093/europace/eus341CrossRefPubMed

14.

Milovanović B, Stojanović L, Milićevik N, Vasić K, Bjelaković B, Krotin M (2010) Cardiac autonomic dysfunction in patients with systemic lupus, rheumatoid arthritis and sudden death risk. Srp Arh Celok Lek 138:26–32. https://doi.org/10.2298/sarh1002026mCrossRefPubMed

15.

Taylor W, Gladman D, Helliwell P, Marchesoni A, Mease P, Mielants H (2006) Classification criteria for psoriatic arthritis: development of new criteria from a large international study. Arthritis Rheum 54:2665–2673. https://doi.org/10.1002/art.21972CrossRefPubMed

16.

Alberti KG, Zimmet PZ (1998) Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med 15:539–553. https://doi.org/10.1002/(sici)1096-9136(199807)15:7%3C539::aid-dia668%3E3.0.co;2-sCrossRefPubMed

17.

Healy PJ, Helliwell PS (2008) Measuring clinical enthesitis in psoriatic arthritis: assessment of existing measures and development of an instrument specific to psoriatic arthritis. Arthritis Rheum 59:686–691. https://doi.org/10.1002/art.23568CrossRefPubMed

18.

Tälli S, Etcheto A, Fautrel B, Balanescu A, Braun J, Cañete JD, de Vlam K, de Wit M, Heiberg T, Helliwell P, Kalyoncu U, Kiltz U, Maccarone M, Niedermayer D, Otsa K, Scrivo R, Smolen JS, Stamm T, Veale DJ, Kvien TK, Gossec L (2016) Patient global assessment in psoriatic arthritis—what does it mean? An analysis of 223 patients from the Psoriatic arthritis impact of disease (PsAID) study. Jt Bone Spine 83:335–340. https://doi.org/10.1016/j.jbspin.2015.06.018CrossRef

19.

Feldman SR, Fleischer AB Jr, Reboussin DM, Rapp SR, Exum ML, Clark AR, Nurre L (1996) The self-administered psoriasis area and severity index is valid and reliable. J Invest Dermatol 106:183–186. https://doi.org/10.1111/1523-1747.ep12329912CrossRefPubMed

20.

Coates LC, Nash P, Kvien TK, Gossec L, Mease PJ, Rasouliyan L, Pricop L, Jugl SM, Gandhi KK, Gaillez C, Smolen JS (2020) Comparison of remission and low disease activity states with DAPSA, MDA and VLDA in a clinical trial setting in psoriatic arthritis patients: 2-year results from the FUTURE 2 study. Semin Arthritis Rheum 50:709–718. https://doi.org/10.1016/j.semarthrit.2020.03.015CrossRefPubMed

21.

Coates LC, Fransen J, Helliwell PS (2010) Defining minimal disease activity in psoriatic arthritis: a proposed objective target for treatment. Ann Rheum Dis 69(1):48–53. https://doi.org/10.1136/ard.2008.102053CrossRefPubMed

22.

Sonmez A, Bayram F, Barcin C, Ozsan M, Kaya A, Gedik V (2013) Waist circumference cutoff points to predict obesity, metabolic syndrome, and cardiovascular risk in Turkish adults. Int J Endocrinol 2013:767202. https://doi.org/10.1155/2013/767202CrossRefPubMedPubMedCentral

23.

(1998) Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults: executive summary. Expert panel on the identification, evaluation, and treatment of overweight in adults. Am J Clin Nutr 68:899–917. https://doi.org/10.1093/ajcn/68.4.899

24.

Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA, Gordon DJ, Krauss RM, Savage PJ, Smith SC Jr, Spertus JA, Costa F (2005) Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation 112:2735–2752. https://doi.org/10.1161/circulationaha.105.169404CrossRefPubMed

25.

(2001) Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). Jama 285:2486–2497. https://doi.org/10.1001/jama.285.19.2486

26.

Wilson PW, D’Agostino RB, Levy D, Belanger AM, Silbershatz H, Kannel WB (1998) Prediction of coronary heart disease using risk factor categories. Circulation 97:1837–1847. https://doi.org/10.1161/01.cir.97.18.1837CrossRefPubMed

27.

Sletten DM, Suarez GA, Low PA, Mandrekar J, Singer W (2012) COMPASS 31: a refined and abbreviated Composite Autonomic Symptom Score. Mayo Clin Proc 87:1196–1201. https://doi.org/10.1016/j.mayocp.2012.10.013CrossRefPubMedPubMedCentral

28.

Fries JF, Spitz P, Kraines RG, Holman HR (1980) Measurement of patient outcome in arthritis. Arthritis Rheum 23:137–145. https://doi.org/10.1002/art.1780230202CrossRefPubMed

29.

McKenna SP, Doward LC, Whalley D, Tennant A, Emery P, Veale DJ (2004) Development of the PsAQoL: a quality of life instrument specific to psoriatic arthritis. Ann Rheum Dis 63:162–169. https://doi.org/10.1136/ard.2003.006296CrossRefPubMedPubMedCentral

30.

Zigmond AS, Snaith RP (1983) The hospital anxiety and depression scale. Acta Psychiatr Scand 67:361–370. https://doi.org/10.1111/j.1600-0447.1983.tb09716.xCrossRefPubMed

31.

Campbell MJ, Swinscow TDV (2009) Statistics at square one. Wiley-Blackwell, West Sussex

32.

Elolemy G, Al Rashidi A, Aboughanima A, Youssry D (2018) Assessment of autonomic dysfunction in patients with primary Sjogren’s syndrome: relation to clinical aspect and immunological profiles. Rheumatology. https://doi.org/10.1093/rheumatology/key075.345CrossRef

33.

Davies K, Ng WF (2021) Autonomic nervous system dysfunction in primary Sjögren’s syndrome. Front Immunol 12:702505. https://doi.org/10.3389/fimmu.2021.702505CrossRefPubMedPubMedCentral

34.

Tomic S, Rajkovaca I, Pekic V, Salha T, Misevic S (2017) Impact of autonomic dysfunctions on the quality of life in Parkinson’s disease patients. Acta Neurol Belg 117:207–211. https://doi.org/10.1007/s13760-016-0739-6CrossRefPubMed

35.

Zinglersen AH, Iversen KK, Leffers HCB, Laugesen E, Fleischer J, Jacobsen S (2021) Characteristics of cardiovascular autonomic dysfunction and association with quality of life in patients with systemic lupus erythematosus. Lupus Sci Med. https://doi.org/10.1136/lupus-2021-000507CrossRefPubMedPubMedCentral

36.

Sloan RP, McCreath H, Tracey KJ, Sidney S, Liu K, Seeman T (2007) RR interval variability is inversely related to inflammatory markers: the CARDIA study. Mol Med 13:178–184. https://doi.org/10.2119/2006%E2%80%9300112.sloanCrossRefPubMedPubMedCentral

37.

Shalimar HR, Deepak KK, Bhatia M, Aggarwal P, Pandey RM (2006) Autonomic dysfunction in systemic lupus erythematosus. Rheumatol Int 26:837–840. https://doi.org/10.1007/s00296-005-0093-0CrossRefPubMed

38.

Karmacharya P, Ogdie A, Eder L (2021) Psoriatic arthritis and the association with cardiometabolic disease: a narrative review. Ther Adv Musculoskelet Dis 13:1759720x21998279. https://doi.org/10.1177/1759720x21998279CrossRefPubMedPubMedCentral

39.

Haroon M, Gallagher P, Heffernan E, FitzGerald O (2014) High prevalence of metabolic syndrome and of insulin resistance in psoriatic arthritis is associated with the severity of underlying disease. J Rheumatol 41:1357–1365. https://doi.org/10.3899/jrheum.140021CrossRefPubMed

40.

Roa I, Del Sol M (2018) Obesity, salivary glands and oral pathology. Colomb Med (Cali) 49:280–287. https://doi.org/10.25100/cm.v49i3.3919CrossRef

41.

Jelinek HF, Md Imam H, Al-Aubaidy H, Khandoker AH (2013) Association of cardiovascular risk using non-linear heart rate variability measures with the framingham risk score in a rural population. Front Physiol 4:186. https://doi.org/10.3389/fphys.2013.00186CrossRefPubMedPubMedCentral

42.

Adlan AM, Lip GY, Paton JF, Kitas GD, Fisher JP (2014) Autonomic function and rheumatoid arthritis: a systematic review. Semin Arthritis Rheum 44:283–304. https://doi.org/10.1016/j.semarthrit.2014.06.003CrossRefPubMed

43.

Cai FZ, Lester S, Lu T, Keen H, Boundy K, Proudman SM, Tonkin A, Rischmueller M (2008) Mild autonomic dysfunction in primary Sjögren’s syndrome: a controlled study. Arthritis Res Ther 10:R31. https://doi.org/10.1186/ar2385CrossRefPubMedPubMedCentral

44.

Verrotti A, Prezioso G, Scattoni R, Chiarelli F (2014) Autonomic neuropathy in diabetes mellitus. Front Endocrinol (Lausanne) 5:205. https://doi.org/10.3389/fendo.2014.00205CrossRef

Titel: Assessment of autonomic dysfunction with the COMPASS-31 and its relationship with disease activity and cardiovascular risks in patients with psoriatic arthritis
verfasst von: Halise Hande Gezer
Didem Erdem Gürsoy
Sevtap Acer Kasman
Mehmet Tuncay Duruöz
Publikationsdatum: 21.03.2022
Verlag: Springer Berlin Heidelberg
Erschienen in: Rheumatology International / Ausgabe 9/2022
Print ISSN: 0172-8172
Elektronische ISSN: 1437-160X
DOI: https://doi.org/10.1007/s00296-022-05110-7

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

25.04.2024 Allergien und Intoleranzreaktionen Nachrichten

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 9/2022

Assessment of TNF-α expression in unstable atherosclerotic plaques, serum IL-6 and TNF-α levels in patients with acute coronary syndrome and rheumatoid arthritis

Vasculitis flare after COVID-19: report of two cases in patients with preexistent controlled IgA vasculitis and review of the literature

The second decade of anti-TNF-a therapy in clinical practice: new lessons and future directions in the COVID-19 era

Post-COVID-Syndrom – wahrscheinlicher bei Koinfektion mit Herpesviren?

Are polymorphisms affecting serum urate, renal urate handling and alcohol intake associated with co-morbidities in gout cases? A case–control study using data from the UK Biobank